Comparison
6q25 1 Microdeletion Syndrome C5925074 vs Abca4 Related Disorder Cn239167
Clinical comparison between 6q25 1 Microdeletion Syndrome and Abca4 Related Disorder CN239167 for differential diagnosis and treatment planning.
6q25 1 Microdeletion Syndrome C5925074
A rare genetic condition where a small piece of chromosome 6 is missing. This can affect multiple systems and cause developmental differences, distinctive features, and various health concerns. Treatment is tailored to individual needs.
Abca4 Related Disorder Cn239167
A genetic retinal disorder caused by ABCA4 gene mutations affecting light-sensing cells in the eye, leading to progressive vision loss that typically begins in childhood or adolescence.
6 comparison axes
Onset
6q25 1 Microdeletion Syndrome C5925074
0-null
Abca4 Related Disorder Cn239167
5-30
Onset patterns differ
Severity
6q25 1 Microdeletion Syndrome C5925074
moderate
Abca4 Related Disorder Cn239167
moderate
Different severity levels
Chronic
6q25 1 Microdeletion Syndrome C5925074
Chronic
Abca4 Related Disorder Cn239167
Chronic
Differing course
Communicable
6q25 1 Microdeletion Syndrome C5925074
No
Abca4 Related Disorder Cn239167
No
Different transmission
Body System
6q25 1 Microdeletion Syndrome C5925074
congenital
Abca4 Related Disorder Cn239167
ophthalmologic
Same/different system
Category
6q25 1 Microdeletion Syndrome C5925074
genetic
Abca4 Related Disorder Cn239167
genetic
Different category
Bottom line
6q25-1-microdeletion-syndrome-C5925074 and abca4-related-disorder-CN239167 have similar characteristics
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 6q25 1 Microdeletion Syndrome C5925074 | Abca4 Related Disorder Cn239167 | Discriminating power |
|---|---|---|---|
| Developmental differences | May include developmental delay and learning differences from early life. | Not a primary feature; cognition is typically unaffected by the retinal disease itself. | High |
| Vision loss | Eye findings may occur but are not the defining feature. | Progressive central vision loss often begins in childhood or adolescence. | High |
| Distinctive features | May involve facial or other congenital differences across systems. | Usually limited to the retina without a multisystem congenital pattern. | Moderate |
When to favor each condition
Choose 6q25 1 Microdeletion Syndrome C5925074 when
Multisystem congenital presentation
Developmental, growth, or structural differences suggest a chromosomal condition.
Moderate
Chromosomal microarray abnormality
A confirmed 6q25.1 deletion supports this diagnosis over an ABCA4 variant.
High
Family history not retinal-specific
A de novo or chromosomal pattern may fit better than ABCA4 inheritance.
Low
Choose Abca4 Related Disorder Cn239167 when
Isolated progressive retinal disease
Childhood or adolescent vision decline without multisystem features favors ABCA4 disease.
Moderate
Biallelic ABCA4 variants
Pathogenic variants in both copies support an ABCA4-related diagnosis.
High
Characteristic retinal imaging
Macular or fleck findings can support, but do not alone prove, ABCA4 disease.
Moderate
How key tests differ
| Test | 6q25 1 Microdeletion Syndrome C5925074 | Abca4 Related Disorder Cn239167 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May show a 6q25.1 deletion. | Expected to be normal for this diagnosis. | A deletion supports the left condition; absence does not exclude other genetic disease. |
| ABCA4 sequencing | Not the primary confirmatory test. | May identify pathogenic variants, often biallelic. | Variant interpretation needs a genetics clinician; one variant may be insufficient. |
| Ophthalmic imaging and function tests | Findings vary and are not specific. | May show progressive macular or retinal changes. | Abnormal imaging is a finding, not by itself a diagnosis. |
Prognosis comparison
6q25 1 Microdeletion Syndrome C5925074
- Outcome
- Chronic and variable; many need ongoing developmental and medical support. Exact outcomes are not established here.
- Factors
- Deletion extent, affected genes, and associated anomalies may influence needs.
Abca4 Related Disorder Cn239167
- Outcome
- Often progressive vision loss; timing and severity vary widely.
- Factors
- Variant type, age at onset, and retinal findings may relate to course, but prediction is uncertain.
Time frame: Left may be evident from infancy; right often begins between childhood and young adulthood.
Neither is communicable. Prognosis requires individualized clinician interpretation.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental and learning needs | May require educational and developmental support. Not expected from the retinal disorder alone. Needs vary; no universal severity is established. |
| Progressive visual impairment | Possible if ocular involvement is present. A central and often progressive concern. Rate and extent differ and should not be predicted from the label alone. |
| Associated congenital health issues | Multiple organ systems may be affected. Generally confined to the eye. Screening should follow individual findings and specialist advice. |
Patient education highlights
- HighDifferent genetic mechanisms
One involves missing chromosome material; the other involves ABCA4 gene variants. They are not interchangeable diagnoses.
- HighSpecialist follow-up
Genetics plus relevant developmental or eye specialists should guide testing and care.
- MediumVariable course
Symptoms, support needs, and vision outcomes vary. Avoid relying on fixed predictions.